Nigeria News App

Join NN App My Account
Stats: 303 members, 1,704 topics. Date:   Sat, 15 2018 at 07:12 am
For more please contact us @ info@nigerianews.app

Nigerian News

FrontPage Forum Must Read Latest Posts Breaking News Entertainment Politics Business Economy Sports Romance General Hausa News
Trending : Buhari 2019 Candidate Court Presidential Presidency Debate
Join NN App Earn by reading news Sign in My earnings Invite friends Income record How it works FAQ Testimonial Income support Today offer

Congo approves clinical trials for Ebola

By - - [General ]

Congolese authorities have authorised clinical trials for four experimental Ebola treatments, which will allow researchers to collect valuable data about their effectiveness, the health ministry said on Saturday.

The ministry said health workers have already administered therapeutic treatments to more than 150 Ebola patients since August in an effort to contain the worst of Democratic Republic of Congo’s 10 outbreaks of the hemorrhagic fever since 1976.

But until now doctors have decided which treatment to use on a case-by-case basis.

In the clinical trial, the choice of treatment will now be randomised.

The health ministry said treatment will still be free of charge.

“Precious information about the effectiveness of the treatments obtained during the clinical trial will allow for the development of these treatments on a wider scale to save more lives,” the ministry said.

The four treatments are mAb114, which was developed by the U.S. government; ZMapp, an intravenous treatment made by Mapp Biopharmaceutical; Remdesivir, made by Gilead Sciences; and Regeneron’s REGN-EB3.

As of Nov. 18, 151 patients had received one of the four drugs.

Of those, 76 had recovered, 44 had died and 31 were still hospitalised — a mortality rate of 37 per cent.

By contrast, among those who had not received treatment, the mortality rate was close to 80 per cent.

The ministry said that the data from the current outbreak would probably not be sufficient to make definitive conclusions about the effectiveness of the treatments and that the trials could continue during future outbreaks.

In spite of the use of the treatments as well as an experimental vaccine manufactured by Merc.

The authorities have struggled to contain the outbreak due to widespread militia violence in eastern Congo and community resistance to health workers.

At least 228 people are believed to have died, and the World Health Organisation said on Nov. 19 that it expects the outbreak to last at least another six months.
http://sunnewsonline.com/congo-approves-clinical-trials-for-ebola/


Like .

Others are reading


14 Comments Nigeria News
Nwoguemmanuel77• 2 days ago
Yes
Reply
LuCkYbOi• 3 weeks ago
Now thats an Afican country
Reply
Sayolara• 3 weeks ago
Hmmm
Reply
Olite1996• 3 weeks ago
great idea
Reply
Raymond• 3 weeks ago
Good
Reply
Irphilippe• 3 weeks ago
Okay
Reply
innkayobami• 3 weeks ago
Good start
Reply
Abdulrazaqmtanko1• 3 weeks ago
Thanks
Reply
ANOINTING• 3 weeks ago
Hmm
Reply
Iamajtofunmi• 3 weeks ago
Hmmm
Reply
Vicharles• 3 weeks ago
Ok
Reply
iammicharles• 3 weeks ago
Hmmmm
Reply
Abidoun• 3 weeks ago
wow
Reply
Fatimabello• 3 weeks ago
Bravo
Reply

(Go Up)

Have a news to share? Contact Email: info@nigerianews.app

NIGERIA NEWS APP (https://www.nigerianews.app) is a website owned by IAR (IJMBway Alevel Registraion) a registered company that pays you for reading news, commenting on every news, sharing our ads on Twitter/ Facebook, inviting friends & family and logging daily. You can make upto ₦200,000 just by inviting people to read Latest Nigerian News & Breaking News in Nigeria. Register today with ₦1,600 to become a member.


© 2018 - Nigerian News App.